Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab (Q77133255)
Jump to navigation
Jump to search
scientific article published on 01 August 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab |
scientific article published on 01 August 1998 |
Statements
Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab (English)
G Dangas
J J Badimon
B S Coller
J T Fallon
S K Sharma
R M Hayes
P Meraj
J A Ambrose
1 August 1998